Clinical Trial Update: The Clinical Evaluation of the Dose of Erythropoietins Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dosing of erythropoietins in adults with chronic kidney disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Giovanni FM Strippoli, MD | Conditions: Kidney Failure, Chronic | Phase 3 | Status: COMPLETED